Calidi Biotherapeutics's total assets for Q3 2025 were $14.03M, an increase of 50.03% from the previous quarter. CLDI total liabilities were $6.83M for the fiscal quarter, a -6.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.